Elidrissi Errahhali Mounia, Elidrissi Errahhali Manal, Boulouiz Redouane, Ouarzane Meryem, Bellaoui Mohammed
Medical Biology Unit, Faculty of Medicine and Pharmacy of Oujda, University Mohammed the First, Oujda, Morocco.
BMC Cancer. 2016 Feb 25;16:159. doi: 10.1186/s12885-016-2205-5.
Hematological malignancies (HM) are a public health problem. The pattern and distribution of diagnosed hematological cancers vary depending on age, sex, geography, and ethnicity suggesting the involvement of genetic and environmental factors for the development of these diseases. To our knowledge, there is no published report on HM in the case of Eastern Morocco. In this report we present for the first time the overall pattern of HM for this region.
Retrospective descriptive study of patients diagnosed with HM between January 2008 and December 2012 in three centres in Eastern Morocco providing cancer diagnosis, treatment or palliative care services. The FAB (French-American-British) classification system has been taken into account in the analysis of myeloid and lymphoid neoplasms.
In this study, a total of 660 cases of HM were registered between January 2008 and December 2012. Overall, 6075 cases of cancers all sites combined were registered during this study period, indicating that HM account for around 10.9 % (660/6075) of all cancers recorded. Among the 660 registered cases of HM, 53 % were males and 47 % were females, with a male to female ratio of 1.1. Thus, overall, men are slightly more affected with HM than women. By contrast, a female predominance was observed in the case of Hodgkin's lymphoma (HL), myeloproliferative neoplasms (MPN), acute myeloid leukemia (AML) and the myelodysplastic syndrome (MDS). HM occur at a relatively young age, with an overall median age at diagnosis of 54 years. Non-Hodgkin's lymphoma (NHL) was the most common HM accounting for 29.7 % of all HM, followed by HL, MPN, multiple myelomas (MM), chronic lymphocytic leukemia (CLL), AML, MDS, acute lymphoblastic leukemia (ALL), and Waldenström macroglobulinemia (WM). The majority of HM cases have been observed among patients aged 60 years and over (40.4 % of HM). Among this age group, NHL was the most common HM. In adolescents, HL was the most frequent HM.
This study provided for the first time the pattern and distribution of HM in Eastern Morocco. Our findings justify the need to establish a regional cancer registry as a first step in blood cancer control in Eastern Morocco.
血液系统恶性肿瘤(HM)是一个公共卫生问题。已诊断血液系统癌症的模式和分布因年龄、性别、地理位置和种族而异,这表明遗传和环境因素参与了这些疾病的发生发展。据我们所知,摩洛哥东部地区尚无关于血液系统恶性肿瘤的公开报告。在本报告中,我们首次呈现了该地区血液系统恶性肿瘤的总体模式。
对2008年1月至2012年12月期间在摩洛哥东部三个提供癌症诊断、治疗或姑息治疗服务的中心被诊断为血液系统恶性肿瘤的患者进行回顾性描述性研究。在分析髓系和淋巴系肿瘤时采用了FAB(法美英)分类系统。
在本研究中,2008年1月至2012年12月期间共登记了660例血液系统恶性肿瘤病例。总体而言,在本研究期间共登记了6075例所有部位的癌症病例,这表明血液系统恶性肿瘤占所有记录癌症的约10.9%(660/6075)。在660例登记的血液系统恶性肿瘤病例中,53%为男性,47%为女性,男女比例为1.1。因此,总体而言,男性受血液系统恶性肿瘤影响略多于女性。相比之下,在霍奇金淋巴瘤(HL)、骨髓增殖性肿瘤(MPN)、急性髓系白血病(AML)和骨髓增生异常综合征(MDS)病例中观察到女性占优势。血液系统恶性肿瘤发病年龄相对较轻,总体诊断时的中位年龄为54岁。非霍奇金淋巴瘤(NHL)是最常见的血液系统恶性肿瘤,占所有血液系统恶性肿瘤的29.7%,其次是HL、MPN、多发性骨髓瘤(MM)、慢性淋巴细胞白血病(CLL)、AML、MDS、急性淋巴细胞白血病(ALL)和华氏巨球蛋白血症(WM)。大多数血液系统恶性肿瘤病例见于60岁及以上患者(占血液系统恶性肿瘤的40.4%)。在这个年龄组中,NHL是最常见的血液系统恶性肿瘤。在青少年中,HL是最常见的血液系统恶性肿瘤。
本研究首次提供了摩洛哥东部地区血液系统恶性肿瘤的模式和分布情况。我们的研究结果证明有必要建立一个区域癌症登记处,作为摩洛哥东部血液癌症控制的第一步。